Nearly 200000 children die every year in India due to measles and its related complications. New vaccine has offered hope of saving around 10 percent of pre-school children who die due to measles.

Robert Sievers from the University of Colorado has created a dry powder inhalable measles vaccine. The biggest advantage of the new vaccine is that it will be delivered straight into the child's lungs when inhaled.

Robert Sievers said, "The vaccine is moving toward clinical trials next year in India. Childhood vaccines that can be inhaled and delivered directly to mucosal surfaces offer significant advantages over injection. They may not only reduce the risk of infection from unsterilized needles, but may also prove more effective against the disease."

For the new vaccine, the weakened measles virus is mixed with supercritical carbon dioxide - part gas, part liquid - to produce microscopic bubbles and droplets. These bubbles are later dried to make an inhalable powder.

The human trails for the medicine will begin after the animal studies testify the effectiveness of the vaccine. The Serum Institute of India will conduct the human trails involving 30 adults.